Risks of Testosterone Replacement Therapy in Men

Overview

Journal Indian J Urol

Specialty Urology

Date 2014 Feb 6

PMID 24497673

Citations 20

Authors

E Charles Osterberg

Aaron M Bernie

Ranjith Ramasamy

Affiliations

Soon will be listed here.

Abstract

Testosterone replacement therapy (TRT) is a widely used treatment for men with symptomatic hypogonadism. The benefits seen with TRT, such as increased libido and energy level, beneficial effects on bone density, strength and muscle as well as cardioprotective effects, have been well-documented. TRT is contraindicated in men with untreated prostate and breast cancer. Men on TRT should be monitored for side-effects such as polycythemia, peripheral edema, cardiac and hepatic dysfunction.

Citing Articles

Hormone correction of dysfunctional metabolic gene expression in stem cell-derived liver tissue.

Kasarinaite A, Ramos M, Beltran-Sierra M, Sutherland E, Rei P, Zhao M Stem Cell Res Ther. 2025; 16(1):130.

PMID: 40069876 PMC: 11899078. DOI: 10.1186/s13287-025-04238-0.

Effect of Elderberry ( L.) Extract Intake on Normalizing Testosterone Concentration in Testosterone Deficiency Syndrome Rat Model Through Regulation of 17β-HSD, 5α-Reductase, and CYP19A1 Expression.

Kim J, An J, Song Y, Jang M, Kong H, Kim S Nutrients. 2024; 16(23).

PMID: 39683564 PMC: 11644235. DOI: 10.3390/nu16234169.

Geographical incidence of testosterone supplementation in total hip and knee arthroplasty.

Coden G, Grant A, Kuznetsov M, Smith E J Orthop. 2024; 61:47-53.

PMID: 39386418 PMC: 11459458. DOI: 10.1016/j.jor.2024.09.002.

Ameliorative effects of elderberry (Sambucus nigra L.) extract and extract-derived monosaccharide-amino acid on H2O2-induced decrease in testosterone-deficiency syndrome in a TM3 Leydig cell.

Lee S, Kim J, Kong H, Kim Y PLoS One. 2024; 19(4):e0302403.

PMID: 38662754 PMC: 11045058. DOI: 10.1371/journal.pone.0302403.

Long-Term Exposure to Supraphysiological Levels of Testosterone Impacts Rat Submandibular Gland Proteome.

Valente-Santos J, Vitorino R, Sousa-Mendes C, Oliveira P, Colaco B, Faustino-Rocha A Int J Mol Sci. 2024; 25(1).

PMID: 38203721 PMC: 10778877. DOI: 10.3390/ijms25010550.

References

Bhasin S, Singh A, Mac R, Carter B, Lee M, Cunningham G . Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003; 24(3):299-311. DOI: 10.1002/j.1939-4640.2003.tb02676.x. View

Tenover J . Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992; 75(4):1092-8. DOI: 10.1210/jcem.75.4.1400877. View

SHAHIDI N . Androgens and erythropoiesis. N Engl J Med. 1973; 289(2):72-80. DOI: 10.1056/NEJM197307122890205. View

Shahani S, Braga-Basaria M, Maggio M, Basaria S . Androgens and erythropoiesis: past and present. J Endocrinol Invest. 2009; 32(8):704-16. DOI: 10.1007/BF03345745. View

Leibowitz R, Dorff T, Tucker S, Symanowski J, Vogelzang N . Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. BJU Int. 2009; 105(10):1397-401. DOI: 10.1111/j.1464-410X.2009.08980.x. View

Trenton A, Currier G . Behavioural manifestations of anabolic steroid use. CNS Drugs. 2005; 19(7):571-95. DOI: 10.2165/00023210-200519070-00002. View

Marks L, Mazer N, Mostaghel E, Hess D, Dorey F, Epstein J . Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006; 296(19):2351-61. DOI: 10.1001/jama.296.19.2351. View

Fuller S, Tan R, Martins R . Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J Alzheimers Dis. 2007; 12(2):129-42. DOI: 10.3233/jad-2007-12202. View

Kenemans P, van der Mooren M . Androgens and breast cancer risk. Gynecol Endocrinol. 2012; 28 Suppl 1:46-9. DOI: 10.3109/09513590.2012.651925. View

10.

Drinka P, Jochen A, Cuisinier M, Bloom R, RUDMAN I, RUDMAN D . Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc. 1995; 43(8):899-901. DOI: 10.1111/j.1532-5415.1995.tb05534.x. View

11.

Eckman A, Dobs A . Drug-induced gynecomastia. Expert Opin Drug Saf. 2008; 7(6):691-702. DOI: 10.1517/14740330802442382. View

12.

Ko Y, Moon D, Moon K . Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up. World J Mens Health. 2013; 31(1):47-52. PMC: 3640152. DOI: 10.5534/wjmh.2013.31.1.47. View

13.

Moffat S, Zonderman A, Metter E, Blackman M, Harman S, Resnick S . Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002; 87(11):5001-7. DOI: 10.1210/jc.2002-020419. View

14.

Morgentaler A . Testosterone therapy for men at risk for or with history of prostate cancer. Curr Treat Options Oncol. 2006; 7(5):363-9. DOI: 10.1007/s11864-006-0004-y. View

15.

Surampudi P, Wang C, Swerdloff R . Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol. 2012; 2012:625434. PMC: 3312212. DOI: 10.1155/2012/625434. View

16.

Saxton J, Zwierska I, Mathur A, Channer K . Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure. BMC Cardiovasc Disord. 2006; 6:46. PMC: 1693568. DOI: 10.1186/1471-2261-6-46. View

17.

Shigehara K, Sugimoto K, Konaka H, Iijima M, Fukushima M, Maeda Y . Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male. 2010; 14(1):53-8. DOI: 10.3109/13685538.2010.518178. View

18.

Einecke D . [Meta-analysis confirms positive effect. Testosterone substitution in heart failure?]. MMW Fortschr Med. 2012; 154(13):33. DOI: 10.1007/s15006-012-0917-2. View

19.

Harman S, Metter E, Tobin J, Pearson J, Blackman M . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001; 86(2):724-31. DOI: 10.1210/jcem.86.2.7219. View

20.

Yurci A, Yucesoy M, Unluhizarci K, Torun E, Gursoy S, Baskol M . Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin Res Hepatol Gastroenterol. 2011; 35(12):845-54. DOI: 10.1016/j.clinre.2011.09.005. View